FDA Suspends Chikungunya Vaccine Over Safety Concerns
The U.S. Food and Drug Administration (FDA) announced on Aug. 22, 2025 that it has suspended the license for French drugmaker Valneva’s chikungunya vaccine, warning that its continued use “poses a danger to public health” following a risk–benefit analysis conducted by the agency’s Center for Biologics Evaluation and Research (CBER). The decision came after reports […]
Pfizer’s COVID-19 Shot Linked to Serious Damage to Eyes
A new peer-reviewed study out of Turkey has found that the Pfizer/BioNTech mRNA COVID-19 biologic (Comirnaty) may cause significant and measurable changes to eye health that, for some individuals, could contribute to long-term or even permanent vision complications. The study, published in Ophthalmic Epidemiology on July 14, 2025 tracked 64 patients over a 2.5-month period, […]
Study Calls for Genetic Screening Before Infants Get Vaccinated
A new peer-reviewed study published in the International Journal of Medical Sciences suggests that genetic differences in how infants metabolize vaccine ingredients may play a critical and previously underrecognized role in sudden infant death syndrome (SIDS)—the unexplained death of an apparently healthy infant under one year old. The authors of the study, published on Apr. […]
Study Shows Pfizer COVID Shot Has 37 Percent Higher Risk of Mortality Than Moderna Shot
According to a new study, adults who received the Pfizer Comirnaty COVID-19 shot were more likely to die than adults who had the Moderna Spikevax COVID-19 shot. The study looked at 9.2 million adults living in Florida who received either Comirnaty or Spikevax within six weeks, from December 2020 through January 2021. Half of the […]
FDA, CDC Halt Use of Chikungunya Vaccine in Adults 60+ After Two Deaths Reported
On May 9, 2025, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) recommended a temporary pause in the use of Ixchiq, a live virus vaccine designed to prevent chikungunya virus infection, in adults aged 60 years and older. The recommendation follows reports of serious post-marketing adverse […]
Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
The American Medical Association (AMA) cites that the influenza vaccine is estimated to be 40-60 percent effective at preventing serious infections or death from the influenza virus that affects up to 40 million Americans every year. However, for the 2024-2025 flu “season” the influenza vaccine not only missed the mark on effectiveness, but is linked […]